MXPA02003174A - Combinacion novedosa de loteprednol y antihistaminicos. - Google Patents

Combinacion novedosa de loteprednol y antihistaminicos.

Info

Publication number: MXPA02003174A
Authority: MX; Mexico
Prior art keywords: loteprednol; antihistamines; novel combination; novel; combination
Prior art date: 1999-09-30

Application number

MXPA02003174A

Other languages

English (en)

Inventor

Jürgen Engel

Original Assignee

Viatris Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-09-30

Filing date

2000-09-26

Publication date

2003-08-20

2000-09-26 Application filed by Viatris Gmbh filed Critical Viatris Gmbh

2003-08-20 Publication of MXPA02003174A publication Critical patent/MXPA02003174A/es

Links

229940125715 antihistaminic agent Drugs 0.000 title 1
239000000739 antihistaminic agent Substances 0.000 title 1
YPZVAYHNBBHPTO-MXRBDKCISA-N loteprednol Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)OCCl)[C@@H]4[C@@H]3CCC2=C1 YPZVAYHNBBHPTO-MXRBDKCISA-N 0.000 title 1
229960001798 loteprednol Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Epidemiology (AREA)
Immunology (AREA)
Rheumatology (AREA)
Ophthalmology & Optometry (AREA)
Otolaryngology (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

MXPA02003174A 1999-09-30 2000-09-26 Combinacion novedosa de loteprednol y antihistaminicos. MXPA02003174A (es)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19947234A DE19947234A1 (de)	1999-09-30	1999-09-30	Neue Kombination von Loteprednol und Antihistaminika
PCT/EP2000/009391 WO2001022955A2 (de)	1999-09-30	2000-09-26	Neue kombination von loteprednol und antihistaminika

Publications (1)

Publication Number	Publication Date
MXPA02003174A true MXPA02003174A (es)	2003-08-20

Family

ID=7924100

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MXPA02003174A MXPA02003174A (es)	1999-09-30	2000-09-26	Combinacion novedosa de loteprednol y antihistaminicos.

Country Status (19)

Country	Link
US (1)	US7022687B1 (es)
EP (1)	EP1216046B1 (es)
JP (2)	JP5524438B2 (es)
AR (1)	AR025923A1 (es)
AT (1)	ATE241988T1 (es)
AU (1)	AU7907300A (es)
BR (1)	BR0014312B1 (es)
CA (1)	CA2387398C (es)
CZ (1)	CZ295090B6 (es)
DE (2)	DE19947234A1 (es)
DK (1)	DK1216046T3 (es)
EE (1)	EE04997B1 (es)
ES (1)	ES2199868T3 (es)
HU (1)	HU229606B1 (es)
MX (1)	MXPA02003174A (es)
PL (1)	PL196843B1 (es)
PT (1)	PT1216046E (es)
TW (1)	TWI224968B (es)
WO (1)	WO2001022955A2 (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE317268T1 (de) *	2001-12-05	2006-02-15	Alcon Inc	Verwendung eines h1-antagonisten und von rimexolon als sicheres steroid zur behandlung von rhinitis
GB2389530B (en)	2002-06-14	2007-01-10	Cipla Ltd	Pharmaceutical compositions
US20090035260A1 (en) *	2002-07-29	2009-02-05	Therapicon Srl	Enhanced nasal composition of active peptide
UA82323C2 (uk) *	2002-08-09	2008-04-10	Меда Фарма Гмбх & Ко. Кг	Нова комбінація глюкокортикоїду та pde-інгібітору для лікування респіраторних захворювань, алергічних захворювань, астми та хронічних обструктивних легеневих захворювань
CA2495830C (en)	2002-08-30	2012-08-21	Altana Pharma Ag	The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis
CA2504200A1 (en) *	2002-11-12	2004-05-27	Alcon, Inc.	The use of an anti-allergy agent and a steroid to treat allergic rhinitis
ES2312844T3 (es)	2002-12-12	2009-03-01	Nycomed Gmbh	Medicamento de combinacion de r, r-formoterol y ciclesonida.
WO2005025578A1 (en)	2003-09-16	2005-03-24	Altana Pharma Ag	Use of ciclesonide for the treatment of respiratory diseases
US20060263350A1 (en) *	2003-09-26	2006-11-23	Fairfield Clinical Trials Llc	Combination antihistamine medication
ITMI20040235A1 (it) *	2004-02-13	2004-05-13	Therapicon Srl	Preparazione farmaceutica per il cavo orale
AU2005229006B9 (en) *	2004-03-25	2011-05-19	Bausch & Lomb Incorporated	Use of loteprednol etabonate for the treatment of dry eye
US20070020330A1 (en) *	2004-11-24	2007-01-25	Medpointe Healthcare Inc.	Compositions comprising azelastine and methods of use thereof
US8758816B2 (en)	2004-11-24	2014-06-24	Meda Pharmaceuticals Inc.	Compositions comprising azelastine and methods of use thereof
PL2486942T3 (pl)	2004-11-24	2019-05-31	Meda Pharmaceuticals Inc	Kompozycje zawierające azelastynę oraz sposoby ich stosowania
JP5683719B2 (ja)	2011-01-04	2015-03-11	イスタ・ファーマシューティカルズ・インコーポレイテッドＩｓｔａＰｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ．	ベポタスチン組成物
EP2854781A4 (en) *	2012-05-25	2016-04-13	Xlear Inc	XYLITOL-BASED ANTIMUKOSAL COMPOSITIONS AND ASSOCIATED METHODS AND COMPOSITIONS
US11744833B2 (en)	2019-04-12	2023-09-05	LA PharmaTech Inc.	Pharmaceutical compositions and methods for treatment of insomnia
US11690849B2 (en)	2019-04-12	2023-07-04	LA PharmaTech Inc.	Method of treating dementia
US11938139B2 (en)	2019-04-12	2024-03-26	LA PharmaTech Inc.	Pharmaceutical compositions and methods for anxiety, depression and other psychiatric disorders
US11389458B2 (en)	2019-04-12	2022-07-19	LA PharmaTech Inc.	Pharmaceutical compositions and methods for treating parkinson's and huntington's disease
US11318144B2 (en)	2019-04-12	2022-05-03	LA PharmaTech Inc.	Compositions and methods for treating Alzheimer's disease and Parkinson's disease
US10898493B2 (en)	2019-04-12	2021-01-26	LA PharmaTech Inc.	Pharmaceutical compositions and methods for psychiatric symptoms of patients with Alzheimer's disease
US10639314B1 (en)	2019-04-30	2020-05-05	LA PharmaTech Inc.	Method of treating Alzheimer's disease
US10966989B2 (en)	2019-04-12	2021-04-06	LA PharmaTech Inc.	Pharmaceutical compositions and methods for treating mental, behavioral, cognitive disorders
AU2021291684A1 (en) *	2020-06-15	2022-12-08	Alkem Laboratories Limited	Combination of alcaftadine and a corticosteroid
US11351179B1 (en)	2021-08-05	2022-06-07	LA PharmaTech Inc.	Pharmaceutical compositions and methods for treatment of psychiatric disorders

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4996335A (en)	1980-07-10	1991-02-26	Nicholas S. Bodor	Soft steroids having anti-inflammatory activity
US4710495A (en)	1980-07-10	1987-12-01	Otsuka Pharmaceutical Co., Ltd.	Soft steroids having anti-inflammatory activity
EP0709099A3 (en) *	1994-09-28	1996-07-24	Senju Pharma Co	Aqueous suspension for nasal administration containing cyclodextrin
WO1997001337A1 (en)	1995-06-29	1997-01-16	Mcneil-Ppc, Inc.	The combination of topical nasal antihistamines and topical nasal steroids
CA2256721A1 (en) *	1996-06-04	1997-12-11	The Procter & Gamble Company	A nasal spray containing an intranasal steroid and an antihistamine
JP4453987B2 (ja) *	1997-01-16	2010-04-21	千寿製薬株式会社	点鼻用水性懸濁液

1999
- 1999-09-30 DE DE19947234A patent/DE19947234A1/de not_active Withdrawn
2000
- 2000-09-26 BR BRPI0014312-0A patent/BR0014312B1/pt not_active IP Right Cessation
- 2000-09-26 US US10/089,436 patent/US7022687B1/en not_active Expired - Fee Related
- 2000-09-26 CZ CZ20021014A patent/CZ295090B6/cs not_active IP Right Cessation
- 2000-09-26 JP JP2001526167A patent/JP5524438B2/ja not_active Expired - Fee Related
- 2000-09-26 ES ES00969303T patent/ES2199868T3/es not_active Expired - Lifetime
- 2000-09-26 EE EEP200200146A patent/EE04997B1/xx not_active IP Right Cessation
- 2000-09-26 MX MXPA02003174A patent/MXPA02003174A/es active IP Right Grant
- 2000-09-26 AU AU79073/00A patent/AU7907300A/en not_active Abandoned
- 2000-09-26 CA CA002387398A patent/CA2387398C/en not_active Expired - Fee Related
- 2000-09-26 DK DK00969303T patent/DK1216046T3/da active
- 2000-09-26 PL PL353486A patent/PL196843B1/pl unknown
- 2000-09-26 WO PCT/EP2000/009391 patent/WO2001022955A2/de not_active Ceased
- 2000-09-26 EP EP00969303A patent/EP1216046B1/de not_active Expired - Lifetime
- 2000-09-26 HU HU0202862A patent/HU229606B1/hu not_active IP Right Cessation
- 2000-09-26 AT AT00969303T patent/ATE241988T1/de active
- 2000-09-26 DE DE50002478T patent/DE50002478D1/de not_active Expired - Lifetime
- 2000-09-26 TW TW089119859A patent/TWI224968B/zh not_active IP Right Cessation
- 2000-09-26 PT PT00969303T patent/PT1216046E/pt unknown
- 2000-09-29 AR ARP000105166A patent/AR025923A1/es not_active Application Discontinuation
2011
- 2011-09-12 JP JP2011198367A patent/JP2012001558A/ja active Pending

Also Published As

Publication number	Publication date
CZ20021014A3 (cs)	2002-06-12
BR0014312B1 (pt)	2012-09-04
ES2199868T3 (es)	2004-03-01
ATE241988T1 (de)	2003-06-15
TWI224968B (en)	2004-12-11
JP5524438B2 (ja)	2014-06-18
CZ295090B6 (cs)	2005-05-18
EP1216046A2 (de)	2002-06-26
EE200200146A (et)	2003-04-15
DE19947234A1 (de)	2001-04-05
AR025923A1 (es)	2002-12-18
WO2001022955A2 (de)	2001-04-05
JP2012001558A (ja)	2012-01-05
EE04997B1 (et)	2008-04-15
AU7907300A (en)	2001-04-30
PT1216046E (pt)	2003-10-31
PL196843B1 (pl)	2008-02-29
WO2001022955A3 (de)	2001-05-17
PL353486A1 (en)	2003-11-17
HU229606B1 (en)	2014-02-28
US7022687B1 (en)	2006-04-04
DE50002478D1 (de)	2003-07-10
BR0014312A (pt)	2002-05-21
JP2003510275A (ja)	2003-03-18
HUP0202862A3 (en)	2003-10-28
CA2387398A1 (en)	2002-03-28
EP1216046B1 (de)	2003-06-04
CA2387398C (en)	2009-05-12
DK1216046T3 (da)	2003-09-29
HUP0202862A2 (hu)	2003-01-28

Legal Events

Date	Code	Title	Description
2004-12-17	FG	Grant or registration
2007-09-13	HC	Change of company name or juridical status

Publication	Publication Date	Title
HU229606B1 (en)	2014-02-28	Novel combination of loteprednol and antihistamines
EG23122A (en)	2004-04-28	Pyrrolcarboxamides and pyrrolcarbothioamides
HRP20060251B1 (hr)	2016-08-12	Supstituirani oksazolidinoni i njihova uporaba
EP1283702A4 (en)	2010-01-13	MEDICAL ASSOCIATION ARRANGEMENT AND METHOD OF THE APPLICATION
AU9667901A (en)	2002-04-15	Mycoattractants and mycopesticides
AU2002245629A1 (en)	2002-09-24	Stabilized therapeutic and imaging agents
AU715620C (en)	2001-11-22	Therapeutic methods and uses
GB9919764D0 (en)	1999-10-27	Thyristors and their manufacture
HUP0203896A3 (en)	2003-05-28	Substituted 8-arylquinoline phosphodiesterase-4-inhibitors and use thereof
AU2002252976A1 (en)	2002-09-19	Hydrazones and their therapeutic use
HUP0201105A2 (hu)	2002-07-29	Peszticid hatású pimetrozin szolvátok, előállításuk és alkalmazásuk
IL146465A0 (en)	2002-07-25	Substituted 3-pyridyl-4-arylpyrroles and related therapeutic and prophylactic methods
PL353487A1 (en)	2003-11-17	Novel combination of loteprednol and beta2
AU2529799A (en)	1999-08-23	Benzofuran-4-carboxamides and their therapeutic use
HUP0203678A3 (en)	2004-12-28	Nitro-sulfobenzamide-derivatives, preparation and use thereof
GB9906330D0 (en)	1999-05-12	Integrated tail-lift and ramp
ZA200109120B (en)	2003-11-13	Use of Arylalkanoylpyridazines.
GB9929581D0 (en)	2000-02-09	Comjpositions and their use
HUP0201800A2 (en)	2002-09-28	Novel calpains and their use
GB9911606D0 (en)	1999-07-21	Composition and use
ZA991021B (en)	2000-02-17	Benzofuran-4-carboxamides and their therapeutic use.
IL145152A0 (en)	2002-06-30	Novel protein and its use
GB9916675D0 (en)	1999-09-15	Enigma-sip and enigma-cell
IL149638A0 (en)	2002-11-10	S-allylmercaptoglutathione and uses thereof
GB9809398D0 (en)	1998-07-01	Immunization and treatment